Literature DB >> 22457082

Comparing the reprogramming efficiency of mouse embryonic fibroblasts, mouse bone marrow mesenchymal stem cells and bone marrow mononuclear cells to iPSCs.

Lei Wang1, Mingyan Zhu, Qingsong Guo, Xiangjun Fan, Yuhua Lu, Shajun Zhu, Yao Wang, Yan Huang, Zhiwei Wang.   

Abstract

Induced pluripotent stem cells have been derived from various cell types via the ectopic expression of a cocktail of transcription factors. Previous studies have reported that induced pluripotent stem cells can be differentiated into multiple somatic cells, providing an invaluable resource in regenerative medicine. In this study, we compared the reprogramming efficiency of mouse embryonic fibroblasts, mouse bone marrow mesenchymal stem cells, and mouse bone marrow mononuclear cells by counting the number of alkaline phosphatase staining positive clones on day 15 after induced pluripotent stem cells induction. We found that a very low number of alkaline phosphatase-staining positive clones were derived from mouse bone marrow mesenchymal stem cells. We then evaluated the pluripotency of the clones by detecting the expression of embryonic stem cells markers and assessing their ability to form embryoid bodies and teratomas. Mouse bone marrow mesenchymal stem cells population is more homogeneous than mouse bone marrow mononuclear cells, which includes a variety of cell types. Our study indicated that the extremely low efficiency of mouse bone marrow mesenchymal stem cells induction implies that mouse bone marrow mesenchymal stem cells may not be a suitable cell type for the induction of induced pluripotent stem cells unless the efficiency of induction can be improved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457082     DOI: 10.1007/s11626-012-9493-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  24 in total

1.  Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.

Authors:  Prashant Mali; Zhaohui Ye; Holly H Hommond; Xiaobing Yu; Jeff Lin; Guibin Chen; Jizhong Zou; Linzhao Cheng
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

2.  Efficient and rapid generation of induced pluripotent stem cells using an alternative culture medium.

Authors:  Xiao-Yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-Long Guo; Xiang Wang; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Cell Res       Date:  2010-02-16       Impact factor: 25.617

3.  Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics.

Authors:  Jiekai Chen; Jing Liu; You Chen; Jiaqi Yang; Jing Chen; He Liu; Xiangjie Zhao; Kunlun Mo; Hong Song; Lin Guo; Shilong Chu; Deping Wang; Ke Ding; Duanqing Pei
Journal:  Cell Res       Date:  2011-03-29       Impact factor: 25.617

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  Direct generation of induced pluripotent stem cells from human nonmobilized blood.

Authors:  Atsushi Kunisato; Mariko Wakatsuki; Haruna Shinba; Toshio Ota; Isao Ishida; Kenji Nagao
Journal:  Stem Cells Dev       Date:  2010-09-14       Impact factor: 3.272

6.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

7.  Generation of induced pluripotent stem cells from human blood.

Authors:  Yuin-Han Loh; Suneet Agarwal; In-Hyun Park; Achia Urbach; Hongguang Huo; Garrett C Heffner; Kitai Kim; Justine D Miller; Kitwa Ng; George Q Daley
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

8.  Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection.

Authors:  Melody Baddoo; Katy Hill; Robin Wilkinson; Dina Gaupp; Catherine Hughes; Gene C Kopen; Donald G Phinney
Journal:  J Cell Biochem       Date:  2003-08-15       Impact factor: 4.429

9.  Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene.

Authors:  Jian Xu; Yuhua Lu; Fei Ding; Xi Zhan; Mingyan Zhu; Zhiwei Wang
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

10.  Reprogramming of pancreatic beta cells into induced pluripotent stem cells.

Authors:  Matthias Stadtfeld; Kristen Brennand; Konrad Hochedlinger
Journal:  Curr Biol       Date:  2008-05-22       Impact factor: 10.834

View more
  2 in total

1.  Culture of iPSCs Derived Pancreatic β-Like Cells In Vitro Using Decellularized Pancreatic Scaffolds: A Preliminary Trial.

Authors:  Jian Wan; Yan Huang; Pengcheng Zhou; Yibing Guo; Cen Wu; Shajun Zhu; Yao Wang; Lei Wang; Yuhua Lu; Zhiwei Wang
Journal:  Biomed Res Int       Date:  2017-04-05       Impact factor: 3.411

2.  Application of Bone Marrow Mesenchymal Stem Cells Effectively Eliminates Endotoxemia to Protect Rat from Acute Liver Failure Induced by Thioacetamide.

Authors:  Ting Jiang; Geng Xia; Bo Yang; Hong-Wei Zhang; Yue-Shan Yin; Cheng-Wei Tang; Jin-Hui Yang
Journal:  Tissue Eng Regen Med       Date:  2022-02-05       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.